Novel anti-cancer candidates from a combinatorial peptide library

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Signal transducer and activator of transcription 3 (STAT3) is a crucial protein implicated in the development and progression of numerous human cancers.
• Targeting STAT3 presents a promising strategy for developing novel anti-cancer therapeutics.

Purpose of the Study:

• To identify novel peptide-based inhibitors of STAT3 using phage display technology.
• To characterize the binding affinity and anti-proliferative activity of identified peptides against cancer cells.

Main Methods:

• Screening of a M13 bacteriophage-displayed combinatorial peptide library using biopanning.
• Isothermal titration calorimetry (ITC) for binding affinity analysis.
• Cell proliferation assays (GI50) and gene expression analysis on tumor cell lines.

Main Results:

• A dodecapeptide (YYVSWPPDMMHY) and a short consensus motif were identified as STAT3 binders.
• Modified peptides achieved high nanomolar affinity (Kd = 500 nM) for STAT3.
• Peptides demonstrated moderate anti-proliferative activity against triple-negative breast cancer cells (GI50 = 50 μM) and reduced expression of key oncoproteins.

Conclusions:

• The identified peptides are potential therapeutic candidates for STAT3-targeted cancer therapy.
• Further development of these agents could lead to novel anti-cancer drugs.
• The study also identified potential novel STAT3-interacting proteins.